Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR0410 in Hemodialysis Subjects With Moderate to Severe Pruritus
NCT04317209Phase 1Unknown
- Sponsor
- Hengrui
- Start
- May 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of SHR0410 in pruritus (4 arms), sponsored by Hengrui. Primary endpoint: Incidence and severity of any adverse events up to 7 days. Status: unknown.
02
Drugs
SHR0410
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT04317209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04317209.